TrialPsychopharmacology2020

A phase 2a randomised, double-blind, placebo-controlled, parallel-group, add-on clinical trial of ebselen (SPI-1005) as a novel treatment for mania or hypomania.

Ann L Sharpley et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.